| Sun, Dec 6, 2009 | | • | ImmunoGen, Inc. Announces Encouraging Clinical Data with Its IMGN901 Compound in the Treatment of Multiple Myeloma
Business Wire (Sun 7:00pm)
| | Fri, Dec 4, 2009 | | • | Cramer's 'Mad Money' Recap: How to Play the Surprising Jobs Report (Update 1)
at TheStreet.com (Fri, Dec 4)
| | • | The Coming Week's Game Plan: Blood, Tech and Jeers
at CNBC (Fri, Dec 4)
| | • | [video] Game Plan
at CNBC (Fri, Dec 4)
| | Thu, Dec 3, 2009 | | • | ImmunoGen, Inc. Announces Conference Call to Discuss Clinical Data Reported at Recent Medical Meetings
Business Wire (Thu, Dec 3)
| | Wed, Dec 2, 2009 | | • | Immunogen's Busy Month, Part II
at Seeking Alpha (Wed, Dec 2)
| | Tue, Dec 1, 2009 | | • | December's Defensive Game Plan for Biotech
at Seeking Alpha (Tue, Dec 1)
| | • | Immunogen's Busy Month, Part I
at Seeking Alpha (Tue, Dec 1)
| | Mon, Nov 30, 2009 | | • | Biotech Calendar: Key Dates for December
at TheStreet.com (Mon, Nov 30)
| | Fri, Nov 27, 2009 | | • | Biotech Stock Mailbag: Targacept
at TheStreet.com (Fri, Nov 27)
| | Tue, Nov 24, 2009 | | • | ImmunoGen, Inc. Announces Clinical Data Presentations on Three TAP Compounds at Upcoming ASH Annual Meeting and Exposition
Business Wire (Tue, Nov 24)
| | Thu, Nov 19, 2009 | | • | UPDATE - ImmunoGen licenses anti-cancer technology to Amgen
at Reuters (Thu, Nov 19)
| | • | ImmunoGen licenses technology to Amgen for $1M
AP (Thu, Nov 19)
| | • | ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use the Company's TAP Technology
Business Wire (Thu, Nov 19)
| | Tue, Nov 17, 2009 | | • | ImmunoGen, Inc. Announces Encouraging Clinical Data with Its IMGN901 Compound in the Treatment of Merkel Cell Carcinoma
Business Wire (Tue, Nov 17)
| | • | Cramer's Stop Trading! Why Is Boeing Flying? (11/16/09)
at Seeking Alpha (Tue, Nov 17)
| | • | Trading Overview for Poniard Pharmaceuticals Inc. Issued by Beacon Equity
GlobeNewswire (Tue, Nov 17)
| | Mon, Nov 16, 2009 | | • | Cramer: Retail Investors Returning to Market?
at CNBC (Mon, Nov 16)
| | Thu, Nov 12, 2009 | | • | You Missed the Best Day to Buy
at Motley Fool (Thu, Nov 12)
| | Wed, Nov 11, 2009 | | • | ImmunoGen Chairman Mitchel Sayare steps down
AP (Wed, Nov 11)
|
Add IMGN News to My Yahoo!:
 
| |
|
0.22% Nasdaq 0.00%
Headlines
